JP2023514188A5 - - Google Patents
Info
- Publication number
- JP2023514188A5 JP2023514188A5 JP2022548528A JP2022548528A JP2023514188A5 JP 2023514188 A5 JP2023514188 A5 JP 2023514188A5 JP 2022548528 A JP2022548528 A JP 2022548528A JP 2022548528 A JP2022548528 A JP 2022548528A JP 2023514188 A5 JP2023514188 A5 JP 2023514188A5
- Authority
- JP
- Japan
- Prior art keywords
- methoxymethyl
- alkyl
- hydroxymethyl
- aryl
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062972002P | 2020-02-09 | 2020-02-09 | |
| US62/972,002 | 2020-02-09 | ||
| US202063002106P | 2020-03-30 | 2020-03-30 | |
| US63/002,106 | 2020-03-30 | ||
| US202063019374P | 2020-05-03 | 2020-05-03 | |
| US63/019,374 | 2020-05-03 | ||
| US202063053592P | 2020-07-18 | 2020-07-18 | |
| US63/053,592 | 2020-07-18 | ||
| PCT/US2021/016862 WO2021158948A1 (en) | 2020-02-09 | 2021-02-05 | Quinuclidinone analogues as anticancer agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023514188A JP2023514188A (ja) | 2023-04-05 |
| JP2023514188A5 true JP2023514188A5 (https=) | 2024-02-14 |
Family
ID=74860395
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022548528A Withdrawn JP2023514188A (ja) | 2020-02-09 | 2021-02-05 | 抗がん剤としてのキヌクリジノン系化合物の応用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230089530A1 (https=) |
| EP (1) | EP4100407A1 (https=) |
| JP (1) | JP2023514188A (https=) |
| CN (1) | CN116034107A (https=) |
| WO (1) | WO2021158948A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022175402A1 (en) * | 2021-02-18 | 2022-08-25 | Aprea Therapeutics Ab | Quinuclidine-3-one derivatives |
| PY2217419A (es) | 2021-03-15 | 2022-09-27 | Novartis Ag | Derivados de pirazolopiridina y sus usos |
| WO2022204109A1 (en) * | 2021-03-22 | 2022-09-29 | Newave Pharmaceutical Inc. | Quinuclidinone analogues as anticancer agents |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| PL2525796T3 (pl) * | 2010-01-21 | 2016-09-30 | Wodny roztwór zawierający 3 chinuklidynony do leczenia choroby hiperproliferacyjnej, autoimmunologicznej i serca | |
| CN104860994A (zh) * | 2014-02-20 | 2015-08-26 | 中国药科大学 | 3-奎宁环酮类含磷化合物的制备及其医药用途 |
-
2021
- 2021-02-05 US US17/797,772 patent/US20230089530A1/en active Pending
- 2021-02-05 EP EP21710652.5A patent/EP4100407A1/en not_active Withdrawn
- 2021-02-05 WO PCT/US2021/016862 patent/WO2021158948A1/en not_active Ceased
- 2021-02-05 JP JP2022548528A patent/JP2023514188A/ja not_active Withdrawn
- 2021-02-05 CN CN202180027033.3A patent/CN116034107A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7260718B2 (ja) | ジアザインドール誘導体及びそのＣｈｋ１阻害剤としての使用 | |
| AU2019341273B2 (en) | Quinazoline derivatives as antitumor agents | |
| JP7279063B2 (ja) | Ｐｄ１／ｐｄ－ｌ１相互作用／活性化の阻害剤としての二環式化合物 | |
| JP7085566B2 (ja) | アポトーシス誘発剤 | |
| JP7215687B2 (ja) | キナーゼ阻害活性を有する化合物、その製造方法及び用途 | |
| AU2022304939A1 (en) | Nitrogen-containing heterocyclic compound, and preparation method therefor, intermediate thereof, and application thereof | |
| US7291630B2 (en) | Azaindoles as inhibitors of c-Jun N-terminal kinases | |
| ES2461967T3 (es) | Compuestos de pirrolo[2,3-d]pirimidina | |
| JP2023514188A5 (https=) | ||
| ES2974494T3 (es) | Compuestos tricíclicos fusionados de piridazinona útiles para tratar las infecciones por ortomixovirus | |
| ES2572105T3 (es) | Compuesto de piridopirimidina o pirimidopirimidina, su método de preparación, su composición farmacéutica y su uso | |
| ES2899694T3 (es) | Compuestos novedosos, su síntesis y sus usos | |
| CA2731946A1 (en) | Flavin derivatives | |
| ES3062921T3 (en) | Preparation method for novel rho-related protein kinase inhibitor and intermediate in preparation method | |
| CA3110520A1 (en) | Thyroid hormone receptor beta agonist compounds | |
| CN118434747A (zh) | 一种含氮杂环化合物、其制备方法、中间体及应用 | |
| JP2012521352A (ja) | ［２−（８，９−ジオキソ−２，６−ジアザビシクロ［５．２．０］ノナ−１（７）−エン−２−イル）エチル］ホスホン酸およびその前駆体を調製するための方法 | |
| KR20170023798A (ko) | 디피콜릴아민 유도체 및 이들의 약제학적 용도 | |
| AU2023292912A1 (en) | Prodrugs of stat3 inhibitors | |
| US20240316054A1 (en) | Novel plk1 protein degradation-inducing compound | |
| CN110407877A (zh) | 新颖螺环芳基磷氧化物的多晶型 | |
| US20230391731A1 (en) | Prodrugs for sustained releasing therapeutic agents and uses thereof | |
| ES2802815A1 (es) | Sal clorhidrato de 3-[2(r)-amino-2-feniletil]-5-(2-fluoro-3-metoxifenil)-1-[2-fluoro-6-(trifluorometil)bencil]-6-metil-1h-pirimidin-2,4(1h,3h)-diona (i) en forma solida, procedimiento para su preparacion y uso de la misma en la sintesis de elagolix | |
| KR20230135625A (ko) | 폐 질환들의 치료를 위한 폐포 2 형 세포 (alveolar type 2 cell) 증식의 소분자 조절제들 | |
| TW202208371A (zh) | 胺基嘧啶基衍生物 |